Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease

NCT00195715 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00195715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00195715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
December 31, 2008
Enrollment
777 (actual)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease